PRY is a 100% local GP/radiology/pathology business.
SHL only generates 9% of revenue from GP, 10% from radiology, and 29% from pathology in Australia.
The other 52% of revenue comes from global pathology with currency tailwinds.
Slight but important differences I think.
Also a milder cold/flu season shouldn't affect the pathology and radiology business too much as GPs don't do blood tests or X-rays frequently for these as they are usually mild to moderate illnesses.
TP=$20-$21?, page-2
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.45 |
Change
1.250(4.77%) |
Mkt cap ! $12.91B | |||
| Open | High | Low | Value | Volume |
| $26.51 | $27.55 | $26.43 | $11.26M | 415.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1129 | $27.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.46 | 184 | 6 |
View Market Depth
| Last trade - 11.19am 19/11/2024 (20 minute delay) ? |
| SHL (ASX) Chart |
